Related Experiment Video
Updated: Mar 19, 2026

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
Published on: August 9, 2019
A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+
E Calura1, S Pizzini1,2, A Bisognin3
1Department of Biology, University of Padova, Padova, Italy.
Abstract:
microRNAs (miRNAs) are relevant in the pathogenesis of primary myelofibrosis (PMF) but our understanding is limited to specific target genes and the overall systemic scenario islacking. By both knowledge-based and ab initio approaches for comparative analysis of CD34+ cells of PMF patients and healthy controls, we identified the deregulated pathways involving miRNAs and genes and new transcriptional and post-transcriptional regulatory circuits in PMF cells. These converge in a unique and integrated cellular process, in which the role of specific miRNAs is to wire, co-regulate and allow a fine crosstalk between the involved processes. The PMF pathway includes Akt signaling, linked to Rho GTPases, CDC42, PLD2, PTEN crosstalk with the hypoxia response and Calcium-linked cellular processes connected to cyclic AMP signaling. Nested on the depicted transcriptional scenario, predicted circuits are reported, opening new hypotheses. Links between miRNAs (miR-106a-5p, miR-20b-5p, miR-20a-5p, miR-17-5p, miR-19b-3p and let-7d-5p) and key transcription factors (MYCN, ATF, CEBPA, REL, IRF and FOXJ2) and their common target genes tantalizingly suggest new path to approach the disease. The study provides a global overview of transcriptional and post-transcriptional deregulations in PMF, and, unifying consolidated and predicted data, could be helpful to identify new combinatorial therapeutic strategy. Interactive PMF network model: http://compgen.bio.unipd.it/pmf-net/.
Insights
MicroRNAs (miRNAs) play a key role in primary myelofibrosis (PMF) pathogenesis. This study reveals novel regulatory circuits and pathways, offering new therapeutic strategies for PMF.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) are implicated in primary myelofibrosis (PMF) pathogenesis, but a comprehensive understanding of their systemic role is lacking.
- Current knowledge is limited to specific target genes, necessitating a broader investigation into regulatory networks.
Purpose of the Study:
- To identify deregulated pathways involving miRNAs and genes in PMF using comparative analysis.
- To uncover novel transcriptional and post-transcriptional regulatory circuits in PMF cells.
- To provide a global overview of molecular dysregulations for potential therapeutic target identification.
Main Methods:
- Comparative analysis of CD34+ cells from PMF patients and healthy controls.
- Knowledge-based and ab initio approaches to identify miRNA-gene interactions.
- Network modeling to visualize and analyze regulatory circuits.
Main Results:
- Identified an integrated cellular process in PMF involving Akt signaling, Rho GTPases, hypoxia response, and calcium-linked signaling.
- Discovered specific miRNAs (e.g., miR-106a-5p, let-7d-5p) and transcription factors (e.g., MYCN, CEBPA) with predicted regulatory roles.
- Established links between miRNAs, transcription factors, and common target genes, suggesting novel disease mechanisms.
Conclusions:
- The study provides a global view of transcriptional and post-transcriptional deregulation in PMF.
- Identified interconnected pathways and regulatory circuits crucial for PMF pathogenesis.
- Findings support the development of new combinatorial therapeutic strategies for PMF.
More Related Videos
06:33Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
12:44Identification of Key Factors Regulating Self-renewal and Differentiation in EML Hematopoietic Precursor Cells by RNA-sequencing Analysis
Published on: November 11, 2014